Steroid Cream for Eczema
FC
Overseen ByFareheen Chowdhury
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: Innovaderm Research Inc.
Prior Safety DataThis treatment has passed at least one previous human trial
Trial Summary
What is the purpose of this trial?
This study is a randomized, intraindividual study to evaluate the short-term efficacy of triamcinolone acetonide (Aristocort® C) in subjects with atopic dermatitis.
Research Team
RB
Robert Bissonnette, MD
Principal Investigator
Innovaderm Research Inc.
Eligibility Criteria
This trial is for adults over 18 with a confirmed diagnosis of active atopic dermatitis (AD), based on specific criteria. They must have stable AD without significant flares for the last 4 weeks and two areas of skin affected. Excluded are those with immune deficiencies, chronic infections, allergies to the study drug, pregnant or breastfeeding women, certain skin types, other interfering skin conditions or cancer within the past 5 years.Inclusion Criteria
I have been diagnosed with active atopic dermatitis.
I have had atopic dermatitis for over 6 months with no severe flare-ups in the last 4 weeks.
I have two skin areas, each at least 6cm by 6cm, suitable for treatment.
Exclusion Criteria
You have a weakened immune system.
I have a long-term infectious disease.
I am allergic to triamcinolone acetonide or components of the study drug.
See 6 more
Timeline
Screening
Participants are screened for eligibility to participate in the trial
1 week
Treatment
Participants receive twice-daily topical application of triamcinolone acetonide (Aristocort® C) or vehicle for 3 days
3 days
Daily visits for application and assessment
Follow-up
Participants are monitored for safety and effectiveness after treatment
1 week
Treatment Details
Interventions
- Triamcinolone Acetonide (Aristocort® C)
Trial Overview The trial tests Triamcinolone Acetonide (Aristocort® C) against a placebo ('Vehicle') in subjects with atopic dermatitis. It's designed as an intraindividual study where each subject receives both treatments on different parts of their body to compare effectiveness directly.
Participant Groups
2Treatment groups
Active Control
Placebo Group
Group I: Triamcinolone Acetonide (Aristocort® C)Active Control1 Intervention
Group II: VehiclePlacebo Group1 Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Innovaderm Research Inc.
Lead Sponsor
Trials
49
Recruited
3,200+
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.